Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to -$1.3 million.

  • Bioventus' Other Working Capital Changes rose 8022.45% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year increase of 21998.6%. This contributed to the annual value of $2.8 million for FY2024, which is 4263.96% up from last year.
  • Per Bioventus' latest filing, its Other Working Capital Changes stood at -$1.3 million for Q3 2025, which was up 8022.45% from -$492000.0 recorded in Q2 2025.
  • Over the past 5 years, Bioventus' Other Working Capital Changes peaked at $12.6 million during Q3 2021, and registered a low of -$8.3 million during Q4 2022.
  • Over the past 5 years, Bioventus' median Other Working Capital Changes value was $392000.0 (recorded in 2021), while the average stood at $478157.9.
  • Over the last 5 years, Bioventus' Other Working Capital Changes had its largest YoY gain of 124657.29% in 2024, and its largest YoY loss of 102562.28% in 2024.
  • Bioventus' Other Working Capital Changes (Quarter) stood at $2.8 million in 2021, then tumbled by 401.05% to -$8.3 million in 2022, then surged by 106.84% to $569000.0 in 2023, then surged by 1246.57% to $7.7 million in 2024, then plummeted by 116.33% to -$1.3 million in 2025.
  • Its Other Working Capital Changes was -$1.3 million in Q3 2025, compared to -$492000.0 in Q2 2025 and -$780000.0 in Q1 2025.